Foreign firms, Indian multinationals and spillovers in the Indian pharmaceutical industry
Purpose – Foreign firms and domestic multinationals have certain internal advantages which may spillover to domestic firms. However, due to heterogeneity across multinationals, it is not necessary that the effect of the spillovers generated by the foreign firm and that generated by the domestic multinational be similar. The purpose of this paper is to empirically find out if the spillovers generated are similar or different in nature. Design/methodology/approach – The study's results are based on a panel regression analysis of 578 firms in the Indian pharmaceutical industry from 1995-2006. Fixed effects as well as the Levinsohn Petrin methodology are used to analyze the research question. Findings – The paper finds that there are differences in the characteristics of foreign firms and Indian multinationals. It also finds differences in the research and development (R&D) spillover effects from foreign firms and those from Indian multinationals. The knowledge or R&D spillover effect of foreign firms on domestic firms is found to be negative, which is interpreted as movement of labor to foreign firms. Indian multinationals seem to have no spillover effect on domestic firms in the Indian pharmaceutical industry. The study also finds that the presence of foreign firms in the Indian pharmaceutical industry has not had a productivity hampering effect on domestic firms. Finally, the study finds some evidence to believe that spillovers in the Indian pharmaceutical industry may vary with size of the domestic firm. Originality/value – There are very few papers in literature that empirically try to find similarity or differences between spillover effects due to foreign firms and those due to domestic multinationals. The study also tries to discern if these spillovers vary with respect to the size of the domestic firm.
If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Volume (Year): 5 (2012)
Issue (Month): 2 (December)
|Contact details of provider:|| Web page: http://www.emeraldinsight.com|
|Order Information:|| Postal: Emerald Group Publishing, Howard House, Wagon Lane, Bingley, BD16 1WA, UK|
Web: http://www.emeraldinsight.com/igdr.htm Email:
When requesting a correction, please mention this item's handle: RePEc:eme:igdrpp:v:5:y:2012:i:2:p:131-150. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Virginia Chapman)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.